Download presentation
Presentation is loading. Please wait.
Published byJanel Walsh Modified over 8 years ago
1
HEPATITIS C TREATMENT SHARED CARE WITH GENERAL PRACTITIONERS SHARED CARE WITH GENERAL PRACTITIONERS
2
HEPATITIS C TREATMENT BACKGROUND TO MODEL OF HCV SHARED CARE @ 250,000 REPORTED HCV INFECTIONS IN AUSTRALIA @ 250,000 REPORTED HCV INFECTIONS IN AUSTRALIA @ 2% OF THIS NO BEING TREATED @ 2% OF THIS NO BEING TREATED FIRST TRIALED THROUGH RBH 2005 FIRST TRIALED THROUGH RBH 2005 2007 - CDU FUNDING TO 10 HOSPITALS IN QLD 2007 - CDU FUNDING TO 10 HOSPITALS IN QLD CNC; PSYCH SUPPORT; ADMIN CNC; PSYCH SUPPORT; ADMIN
3
HEPATITIS C TREATMENT ADVANTAGES OF SHARED CARE CONTINUITY OF CARE WITH GP CONTINUITY OF CARE WITH GP HOLISTIC MODEL HOLISTIC MODEL EASIER AND MORE FLEXIBLE ACCESS FOR PT EASIER AND MORE FLEXIBLE ACCESS FOR PT REDUCTION IN HOSPITAL WAITING LISTS/ MORE PTS TREATED REDUCTION IN HOSPITAL WAITING LISTS/ MORE PTS TREATED
4
HEPATITIS C TREATMENT SHARED CARE – HOW IT WORKS COLLABORATIVE DECISION BETWEEN COLLABORATIVE DECISION BETWEEN PATIENT, GP AND LIVER SPECIALIST PATIENT, GP AND LIVER SPECIALIST LIVER CLINIC REMAINS RESPONSIBLE FOR PT CARE LIVER CLINIC REMAINS RESPONSIBLE FOR PT CARE SHARED CARE NURSE IS CENTRAL TO COMMUNICATION SHARED CARE NURSE IS CENTRAL TO COMMUNICATION NURSE REMAINS ON CALL FOR PT /GP NURSE REMAINS ON CALL FOR PT /GP
5
HEPATITIS C TREATMENT FACTORS WHICH MAY INFLUENCE THE DECISION TO SHARED CARE STABLE MOTIVATED PATIENTS STABLE MOTIVATED PATIENTS UNCOMPLICATED LIVER DISEASE UNCOMPLICATED LIVER DISEASE PATIENT/GP RELATIONSHIP PATIENT/GP RELATIONSHIP INCREASED KNOWLEDGE AND INTEREST INCREASED KNOWLEDGE AND INTEREST
6
FACTORS WHICH MAY INFLUENCE DECISION NOT TO SHARE CARE ADVANCED LIVER DISEASE ADVANCED LIVER DISEASE OTHER COMORBIDITIES OTHER COMORBIDITIES POTENTIAL LACK OF COMPLIANCE POTENTIAL LACK OF COMPLIANCE NO REGULAR GP NO REGULAR GP AFFORABILITY IF NO BULK BILLING AFFORABILITY IF NO BULK BILLING HEPATITIS C TREATMENT
7
HCV REFERRAL PATHWAY PRE REFERRAL WORK UP BY GP PRE REFERRAL WORK UP BY GP LIVER CLINIC ASSESSMENT/ DECISION TO TREAT LIVER CLINIC ASSESSMENT/ DECISION TO TREAT PRE TREATMENT DISCUSSION INVOLVING PARTNER/FAMILY/LIVER CLINIC PSYCH REFERRAL PRE TREATMENT DISCUSSION INVOLVING PARTNER/FAMILY/LIVER CLINIC PSYCH REFERRAL SHARED CARE MODEL DISCUSSED SHARED CARE MODEL DISCUSSED
8
HEPATITIS C TREATMENT REFERRAL PATHWAYS (CTD) S100 SCRIPT WRITTEN S100 SCRIPT WRITTEN NURSE CONTACTS GP TO DISCUSS MODEL NURSE CONTACTS GP TO DISCUSS MODEL LETTER SENT TO GP WITH SCHEDULE OF BLOOD TESTS AND APTS LETTER SENT TO GP WITH SCHEDULE OF BLOOD TESTS AND APTS PT GIVEN COPY OF SCHEDULE PLUS INITIAL PATH FORMS PT GIVEN COPY OF SCHEDULE PLUS INITIAL PATH FORMS COMMENCEMENT OF TREATMENT AT GCH EDUCATION RE: SELF INJECTION COMMENCEMENT OF TREATMENT AT GCH EDUCATION RE: SELF INJECTION
9
HEPATITIS C TREATMENT SCHEDULE FOR SHARED CARE MONTHLY REVIEWS BY GP/ 3 MONTHLY REVIEWS AT GCH LIVER CLINIC MONTHLY REVIEWS BY GP/ 3 MONTHLY REVIEWS AT GCH LIVER CLINIC MONITORING OF PATHOLOGY AND SIDE EFFECTS BY GP AND GCH MONITORING OF PATHOLOGY AND SIDE EFFECTS BY GP AND GCH NEW BLOOD TESTS FORMS AS PER SCHEDULE – S & N OR QML – COPIES TO BOTH DR’S NEW BLOOD TESTS FORMS AS PER SCHEDULE – S & N OR QML – COPIES TO BOTH DR’S
10
HEPATITIS C TREATMENT SHARED CARE SCHEDULE (CTD) SHARED CARE SCHEDULE (CTD) PROGRESS LETTER BACK TO GP AFTER LIVER CLINIC REVIEWS PROGRESS LETTER BACK TO GP AFTER LIVER CLINIC REVIEWS NEW SCRIPTS AT GCH NEW SCRIPTS AT GCH BLOOD TEST FORMS AND NEW SCHEDULE PROVIDED TO PT AND GP BLOOD TEST FORMS AND NEW SCHEDULE PROVIDED TO PT AND GP
11
HEPATITIS C TREATMENT COMMON SIDE EFFECTS FLU-LIKE SYMPTOMS FLU-LIKE SYMPTOMS MOOD SWINGS MOOD SWINGS LETHARGY LETHARGY NAUSEA NAUSEA INSOMNIA INSOMNIA WEIGHT LOSS WEIGHT LOSS
12
HEPATITIS C TREATMENT WHEN TO CONTACT THE SHARED CARE NURSE ANY CONCERNS ABOUT PATHOLOGY LEVELS. ANY CONCERNS ABOUT PATHOLOGY LEVELS. ANY CONCERNS OR QUESTIONS ABOUT SIDE EFFECTS ANY CONCERNS OR QUESTIONS ABOUT SIDE EFFECTS ANY QUESTIONS ABOUT THE SHARED CARE PROCESS ANY QUESTIONS ABOUT THE SHARED CARE PROCESS
13
HEPATITIS C TREATMENT THANK YOU FOR YOUR INTEREST AND PARTICIPATION!
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.